SHARON PALOTAS: Open Payments
NPI 1578566113 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 11 payments from 7 companies in 2025. Trend: 2023 $234 · 2024 $360 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: LOKELMA, Kerendia, Vanrafia, JYNARQUE, VOYXACT, TAVNEOS, JARDIANCE, ROTATEQ.
Industry payments across PA — which companies pay providers there.
